Acciones Wai Yuen Tong Medicine Holdings Limited Hong Kong S.E.
Acciones
0897
BMG9421Y2175
Farmacéuticos
Ventas 2022 | 1391,41 M 178 M 164 M | Ventas 2023 | 1286,43 M 165 M 152 M | Capitalización | 434 M 55,47 M 51,15 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -109 M -13,94 M -12,86 M | Resultado Neto 2023 | -20 M -2,56 M -2,36 M | VE / Ventas 2022 | 1,1 x |
Deuda neta 2022 | 1174,47 M 150 M 139 M | Deuda neta 2023 | 1196,18 M 153 M 141 M | VE / Ventas 2023 | 1,27 x |
P/E ratio 2022 |
-3,28
x | P/E ratio 2023 |
-21,3
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 27,98 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ching Ho Tang
CEO | Chief Executive Officer | 62 | 28/08/01 |
Yuen Wo Tsang
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/18 |
Seung Ming Wong
AUD | Comptroller/Controller/Auditor | 52 | 01/02/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ka Fai Li
BRD | Director/Board Member | 69 | 17/03/15 |
Ching Ho Tang
CEO | Chief Executive Officer | 62 | 28/08/01 |
Man Ho Siu
BRD | Director/Board Member | 50 | 01/08/01 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+37,29 % | 6020,86 M | |
-21,28 % | 4189,39 M | |
+4,52 % | 3254,87 M | |
-18,16 % | 2873,58 M | |
-7,70 % | 2374,9 M | |
+41,50 % | 1885,2 M | |
-4,05 % | 1579,81 M | |
-15,56 % | 1540,37 M | |
-14,62 % | 1501,64 M |